Latest stories on RVPH
Reviva Pharmaceuticals (RVPH) Q3 Earnings Beat Expectations with GAAP EPS of -$0.17
GuruFocus63 · neutralearnings
Reviva Pharmaceuticals GAAP EPS of -$0.17 beats by $0.23
Seeking Alpha64 · neutralearnings
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) files 8-K: Items 2.02, 7.01, 9.01
SEC 8-K50 · neutralgeneral
Reviva Reports Third Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire58 · neutralearnings
Reviva to Participate in the Lytham Partners Fall 2026 Investor Conference
GlobeNewswire55 · neutralgeneral
Reviva to Participate in the Lytham Partners Fall 2026 Investor Conference
Business Insider55 · neutralgeneral
Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio
Business Insider56 · neutralproduct/pr
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) files 8-K
SEC 8-K50 · neutralgeneral
Reviva Pharmaceuticals GAAP EPS of -$0.19 beats by $0.17
Seeking Alpha56 · neutralearnings
Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Business Insider56 · neutralgeneral
Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire56 · neutralearnings
Reviva Pharmaceuticals GAAP EPS of -$0.46 misses by $0.11
Seeking Alpha34 · bearishearnings